Skip to search formSkip to main contentSkip to account menu

tabimorelin

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Dipeptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
A clinical study investigating the pharmacokinetic interaction between NN703 (tabimorelin), a potential inhibitor of CYP3A4 activity, and midazolam, a CYP3A4 substrate
ObjectiveNN703 (tabimorelin) is an orally active growth hormone (GH) secretagogue intended for use as an alternative to daily… 
2000
2000
The pharmacokinetics, pharmacodynamics, safety and tolerability of a single dose of NN703, a novel orally active growth hormone secretagogue in healthy male volunteers.
The aim of the present study was to investigate the pharmacodynamics, pharmacokinetics, safety and tolerability of a single dose… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)